A decrease in proportion of patients presenting with side-effects was observed in the China group from day 0 to day 6 of follow-up ( 53.9 % -23.3 % ) whereas the proportion of patients with side-effects in the Standard group did not change significantly ( 85.9 % on day 0 vs. 82.5 % on day 6 ) .